Indinavir-fluconazole interaction.
作者信息
Bellibas S E
出版信息
Antimicrob Agents Chemother. 1999 Feb;43(2):432-3. doi: 10.1128/AAC.43.2.432.
Abstract
摘要
相似文献
1
Indinavir-fluconazole interaction.茚地那韦与氟康唑的相互作用。
Antimicrob Agents Chemother. 1999 Feb;43(2):432-3. doi: 10.1128/AAC.43.2.432.
2
3
4
Drugs for HIV infection.用于治疗HIV感染的药物。
Med Lett Drugs Ther. 1997 Dec 12;39(1015):111-6.
5
Reduction in oropharyngeal candidiasis following introduction of protease inhibitors.引入蛋白酶抑制剂后口咽念珠菌病减少。
AIDS. 1998 Mar 5;12(4):447-8.
6
Fluconazole prevents yeast infections in women with HIV.
AIDS Patient Care STDS. 1996 Oct;10(5):310.
7
[Cryptococcal meningoencephalitis related to HIV infection with resistance to fluconazole, relapse, and IRIS].[与HIV感染相关的新型隐球菌性脑膜脑炎，对氟康唑耐药、复发及免疫重建炎症综合征]
Med Klin (Munich). 2009 Jan 15;104(1):58-62. doi: 10.1007/s00063-009-1007-9. Epub 2009 Jan 14.
8
Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.
Ann Intern Med. 1996 Mar 15;124(6):573-6. doi: 10.7326/0003-4819-124-6-199603150-00006.
9
Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis.一名合并结核病的HIV感染患者成功维持利托那韦增强的茚地那韦和依非韦伦治疗
AIDS. 2006 Apr 24;20(7):1083-5. doi: 10.1097/01.aids.0000222090.52035.b2.
10
Discontinuation of secondary prophylaxis for cryptococcal meningitis in HIV-infected patients responding to highly active antiretroviral therapy.在接受高效抗逆转录病毒治疗且有反应的HIV感染患者中停止隐球菌性脑膜炎的二级预防。
AIDS. 2000 Nov 10;14(16):2615-7. doi: 10.1097/00002030-200011100-00029.
引用本文的文献
1
MDR- and CYP3A4-mediated drug-drug interactions.多药耐药（MDR）和细胞色素P450 3A4（CYP3A4）介导的药物相互作用。
J Neuroimmune Pharmacol. 2006 Sep;1(3):323-39. doi: 10.1007/s11481-006-9034-2. Epub 2006 Aug 2.
本文引用的文献
1
Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.氟康唑对人类免疫缺陷病毒感染患者茚地那韦药代动力学的影响。
Antimicrob Agents Chemother. 1998 Feb;42(2):223-7. doi: 10.1128/AAC.42.2.223.
2
Update: clinically significant cytochrome P-450 drug interactions.更新：具有临床意义的细胞色素P-450药物相互作用。
Pharmacotherapy. 1998 Jan-Feb;18(1):84-112.
3
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study.接受利托那韦加沙奎那韦治疗的晚期HIV感染患者的毒性、疗效、血浆药物浓度及蛋白酶突变。瑞士HIV队列研究。
AIDS. 1997 Oct;11(12):F95-9. doi: 10.1097/00002030-199712000-00002.
4
Resistance to anti-human immunodeficiency virus therapeutic agents.
Adv Exp Med Biol. 1995;390:187-95. doi: 10.1007/978-1-4757-9203-4_16.
5
Clinical pharmacokinetics of fluconazole.氟康唑的临床药代动力学
Clin Pharmacokinet. 1993 Jan;24(1):10-27. doi: 10.2165/00003088-199324010-00002.
Zotero 插件